# Study of Weekly ALTU-238 Compared With Daily Nutropin AQ in Prepubertal Children With Growth Hormone Deficiency

> **NCT00837863** · PHASE2 · UNKNOWN · sponsor: **Altus Pharmaceuticals** · enrollment: 36 (estimated)

## Conditions studied

- Growth Hormone Deficiency

## Interventions

- **DRUG:** Somatropin
- **DRUG:** Somatropin
- **DRUG:** Somatropin
- **DRUG:** Somatropin

## Key facts

- **NCT ID:** NCT00837863
- **Lead sponsor:** Altus Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-03
- **Primary completion:** 2010-09
- **Final completion:** —
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2009-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00837863

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00837863, "Study of Weekly ALTU-238 Compared With Daily Nutropin AQ in Prepubertal Children With Growth Hormone Deficiency". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT00837863. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*